Seeing Is Believing
Currently out of the existing stock ratings of Salveen Richter, 96 are a HOLD (34.53%), 164 are a BUY (58.99%), 18 are a SELL (6.47%).
Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 64.83% that have a potential upside of 34.32% achieved within 269 days.
Salveen Richter’s has documented 557 price targets and ratings displayed on 49 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on APLS, Apellis Pharmaceuticals at 06-Nov-2024.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $109 was fulfilled within 1 day with a profit of $13 (13.54%) receiving and performance score of 135.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$27
$10.58 (64.43%)
$27
13 days ago
(07-Nov-2024)
8/22 (36.36%)
$9.79 (56.89%)
119
Buy
$28
$11.58 (70.52%)
$28
13 days ago
(07-Nov-2024)
0/4 (0%)
$10.79 (62.70%)
Hold
1 months 10 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
Buy
$23
$6.58 (40.07%)
$30
3 months 12 days ago
(08-Aug-2024)
0/3 (0%)
$7.28 (46.31%)
Buy
$20
$3.58 (21.80%)
$28
3 months 13 days ago
(07-Aug-2024)
16/21 (76.19%)
$4.83 (31.84%)
184
Which stock is Salveen Richter is most bullish on?
Which stock is Salveen Richter is most reserved on?
What Year was the first public recommendation made by Salveen Richter?